The results suggest that HMGB1 polymorphisms are significantly inversely associated with EGFR mutations among smoking patients with NSCLC and, furthermore, that HMGB1 variants and smoking may contribute to the pathological development of NSCLC [175]. The gene discussed is HMGB1; the disease is non-small cell lung carcinoma.